‘We’re flying blind’: Study calls for disaggregated health data A global analysis has highlighted a need for better data to address hidden inequities. But a GP expert is concerned about further bias.
New medication for treatment resistant depression added to PBS The nasal spray is available from 1 May to eligible patients, but a GP expert remains concerned about its accessibility.
The rise in self-testing and the role of GPs The market for accessible home tests ranging from vitamin deficiency to STIs is booming. How far is this shifting the role of general practice?
Opioid agonist treatment prevents hundreds of suicides: Study Australian research predicts the treatment has prevented around 300 suicide deaths among NSW patients with opioid use disorder.
Changes coming to MBS telehealth regulations The changes, coming into effect from 1 November, will be tied to a patient’s registered MyMedicare practice.
Do GPs know enough about this ‘debilitating’ disorder? Experts agree there has been a dire lack of education around PMDD, but GPs could be in the ‘ideal situation’ to help.
New guide to support GPs ease cancer recurrence anxiety With 60% of patients anxious their cancer will return, the three-step clinical pathway is designed to offer practical and streamlined advice.
In Practice: Call for GPs to join dementia study New research aims to gather GPs’ understanding of and attitudes to dementia diagnosis and management, and the use of blood-based biomarkers.
Action taken amid continuing PrEP shortage As supply of the HIV prevention medication continues to be disrupted, the Federal Government has listed a US brand on the PBS to shore up access.
New national shortage of PrEP part of ‘concerning’ trend GPs are being warned to plan ahead with their patients, as the TGA confirms a national shortage of the HIV prevention drug.